| NCT ID | NCT05001477 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Profound Medical Inc. |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-10-27 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-10-27 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Eligibility Criteria
Inclusion Criteria 1. Male 2. \>18 years old 3. Candidate for TULSA-PRO treatment 4. willing and able to sign the Informed Consent form Exclusion Criteria: None.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05001477 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05001477 currently recruiting?
Yes, NCT05001477 is actively recruiting participants. Contact the research team at gclarke@profoundmedical.com for enrollment information.
Where is the NCT05001477 trial being conducted?
This trial is being conducted at West Hills, United States, Jacksonville, United States, York, United States, Dallas, United States and 1 additional location.
Who is sponsoring the NCT05001477 clinical trial?
NCT05001477 is sponsored by Profound Medical Inc.. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.